• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

强啡肽A(1-11)-NH₂环内酰胺肽类似物的设计、合成及生物活性

Design, synthesis, and biological activities of cyclic lactam peptide analogues of dynorphine A(1-11)-NH2.

作者信息

Lung F D, Collins N, Stropova D, Davis P, Yamamura H I, Porreca F, Hruby V J

机构信息

Department of Chemistry, University of Arizona, Tucson, Arizona 85721, USA.

出版信息

J Med Chem. 1996 Mar 1;39(5):1136-41. doi: 10.1021/jm950369c.

DOI:10.1021/jm950369c
PMID:8676350
Abstract

We previously have reported four possible binding conformation of dynorphin A (Dyn A) for the central kappa opioid receptors, induced by the address sequence, using a molecular mechanics energy minimization approach. The lowest energy conformation was found to exhibit an alpha-helical conformation in the cyclized address sequence. It was suggested that an alpha-helical conformation in the cyclized address sequence or a helical conformation induced by the conformational characteristics of the message sequence may be important for binding potency and kappa opioid receptor selectivity. Side chain to side chain lactam bridges between the i and i + 4 positions have been shown to stabilize alpha-helical conformation. Thus, a series of cyclic lactam analogues of dynorphin A(1-11)-NH2 have been designed, synthesized and evaluated by the guinea pig brain (GPB) binding assay and guinea pig ileum (GPI) bioassay to evaluate the conformational analysis prediction and, further, to investigate the conformational requirements for high potency and selectivity for kappa opioid receptors. Positions 2-6, 3-7, and 5-9 were chosen as the sites for incorporating cyclic conformational constraints. Cyclization between D-Asp(2) and Lys(6) in c[D-Asp(2),Lys(6)]Dyn A(1-11)-NH2 led to an analogue with pronounced potency and selectivity enhancement for the mu opioid receptor, whereas cyclization between D-Asp(3) and Lys(7) in c[D-Asp(3),Lys(7)]Dyn A(1-11)-NH2 led to a potent ligand (IC(50) 4.9 nM) with kappa receptor selectivity. The other analogues in the series proved to be less selective. The biological results led to the suggestion that the binding conformation for the kappa receptor may have structural requirements that are distinct from those of mu and delta receptors. Interestingly, analogues with a D-Asp at position 2, 3, or 9 were found to be more potent for the kappa receptor than analogues with an L-Asp at the same positions. It is suggested that the incorporation of D-Asp into position 2, 3, or 9 of Dyn A(1-11)-NH2 may have stereochemical and conformational effects on the nearby amino acids which can help discriminate the preference between kappa, mu, and delta receptors.

摘要

我们之前报道过,使用分子力学能量最小化方法,强啡肽A(Dyn A)由地址序列诱导产生的四种可能与中枢κ阿片受体结合的构象。发现能量最低的构象在环化的地址序列中呈现α-螺旋构象。有人提出,环化地址序列中的α-螺旋构象或由信息序列的构象特征诱导的螺旋构象对于结合亲和力和κ阿片受体选择性可能很重要。已表明i和i + 4位之间的侧链至侧链内酰胺桥可稳定α-螺旋构象。因此,设计、合成了一系列强啡肽A(1-11)-NH2的环内酰胺类似物,并通过豚鼠脑(GPB)结合试验和豚鼠回肠(GPI)生物测定进行评估,以评估构象分析预测,进而研究对κ阿片受体高效力和选择性的构象要求。选择2-6、3-7和5-9位作为引入环构象限制的位点。c[D-Asp(2),Lys(6)]Dyn A(1-11)-NH2中D-Asp(2)和Lys(6)之间的环化产生了一种对μ阿片受体具有显著效力和选择性增强的类似物,而c[D-Asp(3),Lys(7)]Dyn A(1-11)-NH2中D-Asp(3)和Lys(7)之间的环化产生了一种对κ受体具有选择性(IC(50)4.9 nM)的强效配体。该系列中的其他类似物选择性较低。生物学结果表明,κ受体的结合构象可能具有与μ和δ受体不同的结构要求。有趣的是,发现在2、3或9位带有D-Asp的类似物对κ受体的效力比在相同位置带有L-Asp的类似物更强。有人提出,在Dyn A(1-11)-NH2的2、3或9位引入D-Asp可能对附近氨基酸产生立体化学和构象影响,这有助于区分κ、μ和δ受体之间的偏好。

相似文献

1
Design, synthesis, and biological activities of cyclic lactam peptide analogues of dynorphine A(1-11)-NH2.强啡肽A(1-11)-NH₂环内酰胺肽类似物的设计、合成及生物活性
J Med Chem. 1996 Mar 1;39(5):1136-41. doi: 10.1021/jm950369c.
2
Synthesis and opioid activity of conformationally constrained dynorphin A analogues. 2. Conformational constraint in the "address" sequence.构象受限强啡肽A类似物的合成与阿片样活性。2. “靶向”序列中的构象限制。
J Med Chem. 1997 Apr 11;40(8):1211-8. doi: 10.1021/jm960753p.
3
Development of highly potent and selective dynorphin A analogues as new medicines.开发高效且具选择性的强啡肽A类似物作为新型药物。
J Pept Res. 2005 Nov;66(5):263-76. doi: 10.1111/j.1399-3011.2005.00302.x.
4
Synthesis and opioid activity of side-chain-to-side-chain cyclic dynorphin A-(1-11) amide analogues cyclized between positions 2 and 5. 1. Substitutions in position 3.2位和5位之间侧链至侧链环化的环强啡肽A-(1-11)酰胺类似物的合成及阿片样活性。1. 3位取代。
J Med Chem. 2004 Jan 15;47(2):446-55. doi: 10.1021/jm030298e.
5
Prediction of the conformational requirements for binding to the kappa-opioid receptor and its subtypes. I. Novel alpha-helical cyclic peptides and their role in receptor selectivity.与κ-阿片受体及其亚型结合的构象要求预测。I. 新型α-螺旋环肽及其在受体选择性中的作用。
Biopolymers. 1994 Sep;34(9):1231-41. doi: 10.1002/bip.360340911.
6
Effects of modifications of residues in position 3 of dynorphin A(1-11)-NH2 on kappa receptor selectivity and potency.强啡肽A(1-11)-NH2第3位残基修饰对κ受体选择性和效价的影响。
J Med Chem. 1996 Jun 21;39(13):2456-60. doi: 10.1021/jm950655o.
7
Effects of the substitution of Phe4 in the opioid peptide [D-Ala8]dynorphin A-(1-11)NH2.阿片肽[D-Ala8]强啡肽A-(1-11)NH2中苯丙氨酸4被取代的影响。
J Med Chem. 2003 Sep 11;46(19):4002-8. doi: 10.1021/jm030075o.
8
[Nalpha-benzylTyr1,cyclo(D-Asp5,Dap8)]- dynorphin A-(1-11)NH2 cyclized in the "address" domain is a novel kappa-opioid receptor antagonist.在“地址”结构域环化的[Nα-苄基酪氨酸1,环(D-天冬氨酸5,二氨基庚二酸8)]-强啡肽A-(1-11)NH₂是一种新型κ-阿片受体拮抗剂。
J Med Chem. 2005 Jul 14;48(14):4500-3. doi: 10.1021/jm050105i.
9
Biological and conformational examination of stereochemical modifications using the template melanotropin peptide, Ac-Nle-c[Asp-His-Phe-Arg-Trp-Ala-Lys]-NH2, on human melanocortin receptors.使用模板促黑素肽Ac-Nle-c[Asp-His-Phe-Arg-Trp-Ala-Lys]-NH2对人黑皮质素受体进行立体化学修饰的生物学和构象研究。
J Med Chem. 1997 May 23;40(11):1738-48. doi: 10.1021/jm960845e.
10
Design, synthesis, and biological properties of highly potent cyclic dynorphin A analogues. Analogues cyclized between positions 5 and 11.
J Med Chem. 1994 Nov 11;37(23):3910-7. doi: 10.1021/jm00049a010.

引用本文的文献

1
Design, synthesis, and pharmacological activities of dynorphin A analogues cyclized by ring-closing metathesis.通过闭环复分解环化的强啡肽A类似物的设计、合成及药理活性
J Med Chem. 2009 Sep 24;52(18):5619-25. doi: 10.1021/jm900577k.
2
Homology modeling of opioid receptor-ligand complexes using experimental constraints.利用实验约束条件对阿片受体-配体复合物进行同源建模。
AAPS J. 2005 Oct 5;7(2):E434-48. doi: 10.1208/aapsj070243.